Showing results (431-440 of 1,404) with videos related to
Sort By:
Pageof 141
Circulation|April 18, 2001
Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in miceM Levi, L Moons, A Bouché, et al.Psychosomatic Medicine|March 1, 1993
Hostility and differences between clinic, self-determined, and ambulatory blood pressureL D Jamner, D Shapiro, K K Hui, et al.Clinical Pediatrics|July 23, 1999
Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezingE M Mahabee-Gittens, D T Bachman, E D Shapiro, et al.American Journal of Hypertension|January 1, 1997
Reduction in drug requirements for hypertension by means of a cognitive-behavioral interventionD Shapiro, K K Hui, M E Oakley, et al.Psychological Medicine|February 1, 1992
Immunological variability associated with experimentally-induced positive and negative affective statesA D Futterman, M E Kemeny, D Shapiro, et al.Gastroenterology|May 12, 2005
Current status of gastrointestinal carcinoidsIrvin M Modlin, Mark Kidd, Igor Latich, et al.Plastic and Reconstructive Surgery|June 1, 2005
The role of lacrimal intubation in the management of facial trauma and tumor resectionHenry M Spinelli, Michael D Shapiro, Lisa L Wei, et al.Journal of the National Cancer Institute|April 9, 2009
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated researchAntonello Punturieri, Eva Szabo, Thomas L Croxton, et al.Journal of Clinical Lipidology|January 29, 2026
Myocardial infarction risk and the clinical significance of metabolic syndrome in the absence of hypertension and diabetes: Insights from a large cohort screening populationSoroush Masrouri, Navid Ebrahimi, Diar Zooravar, et al.Journal of Clinical Lipidology|May 28, 2019
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapyBruce A Warden, Jessica Minnier, Gerald F Watts, et al.Pageof 141